PLAY PODCASTS
The Faceless Middleman Between You and Your Doctor
Episode 90

The Faceless Middleman Between You and Your Doctor

A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk. Policies like step therapy and prior authorization are forcing individuals into treatments not recommended by their doctors—often with devastating consequences. In this episode, we hear from a patient who endured months of suffering due to her insurer's 'fail-first' requirements. We also talk with a doctor navigating this impossible system and a biotech leader fighting to ensure innovative treatments reach the patients who need them most. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

I AM BIO · Deb Constien Patient from Madison Wisconsin, Harrison Nguyen MD MBA MPH FAAD, Frank Watanabe President & CEO Arcutis Biotherapeutics Inc

November 19, 202426m 43s

Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk. Policies like step therapy and prior authorization are forcing individuals into treatments not recommended by their doctors—often with devastating consequences. In this episode, we hear from a patient who endured months of suffering due to her insurer's 'fail-first' requirements. We also talk with a doctor navigating this impossible system and a biotech leader fighting to ensure innovative treatments reach the patients who need them most. 

Follow us on LinkedIn, X, Facebook and Instagram

Visit us at https://www.bio.org/

Topics

safe step actfrank watanabedrug developersinsurance barriersatopic dermatitispatient well-beingprior authorizationfail firststep therapyfda approvalinsurance companiesdermatologyrebatesdrug developmenthigher tier medicationaciphexpharmacy benefit managersdr. harrison nguyenrheumatoid arthritisinsurance denialpbmsclinical guidelinesdeb consteininsurance appealsdoctor/patient relationshiparcutis biotherapeuticsdoctor recommendationutilization management